Table 1.
Patient time contributing to CYP2D6 substrate cohorts
| CYP2D6 substratea | No. of patients | Time before overlapping dispensing (person-months) | Time with overlapping dispensing (person-months) | Overlapping time (%) |
|---|---|---|---|---|
| Tramadol | 10,200 | 10,110 | 12,195 | 46.1 |
| Donepezil | 1467 | 9799 | 9944 | 41.3 |
| Amitriptyline/nortriptyline | 4068 | 18,638 | 18,101 | 38.6 |
| Aripiprazole | 1675 | 9589 | 8321 | 38.4 |
| Hydrocodone | 17,998 | 20,346 | 17,184 | 36.5 |
| Tamsulosin | 8029 | 51,734 | 39,259 | 35.2 |
| Citalopram/escitalopram | 8813 | 70,593 | 48,003 | 32.2 |
| Duloxetine/venlafaxine | 8991 | 81,973 | 55,202 | 31.4 |
| Metoprolol/carvedilol | 10,274 | 106,558 | 64,591 | 29.8 |
| Tolterodine | 4622 | 23,902 | 9385 | 22.6 |
CYP cytochrome P450
aPresented by decreasing percentage of overlapping time